Kiora Pharmaceuticals, Inc.
KPRX
$2.50
-$0.08-3.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.22% | -33.27% | -25.71% | -22.93% | 991.46% |
| Total Receivables | 280.56% | 24.25% | -15.22% | 3.06% | -57.49% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -34.24% | 269.97% | 388.82% | 416.46% | 775.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -26.79% | -28.30% | -22.29% | -19.04% | 526.97% |
|
|
|||||
| Total Current Assets | -26.79% | -28.30% | -22.29% | -19.04% | 526.97% |
| Net Property, Plant & Equipment | 504.97% | 210.50% | 212.69% | 46.55% | -45.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -100.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -68.32% | 19,521.51% | 18,502.20% | 15,429.89% | -23.16% |
| Total Assets | -33.52% | -22.45% | -21.73% | -19.84% | 166.08% |
|
|
|||||
| Total Accounts Payable | 155.13% | -63.43% | 5.17% | 191.71% | 101.45% |
| Total Accrued Expenses | 0.18% | 37.70% | 30.34% | -12.85% | 63.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 602.99% | 366.77% | 240.38% | 49.48% | -50.32% |
| Total Finance Division Other Current Liabilities | -95.71% | -97.71% | 1,037.10% | -- | -- |
| Total Other Current Liabilities | -95.71% | -97.71% | 1,037.10% | -- | -- |
| Total Current Liabilities | -39.56% | -26.85% | 92.39% | 231.11% | 267.73% |
|
|
|||||
| Total Current Liabilities | -39.56% | -26.85% | 92.39% | 231.11% | 267.73% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 502.96% | 533.16% | 614.18% | 88.58% | -43.48% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -8.34% | -5.87% | 5.46% | -15.92% | -20.75% |
| Total Liabilities | -24.22% | -12.11% | 27.30% | 36.94% | 41.07% |
|
|
|||||
| Common Stock & APIC | 0.69% | 0.64% | 0.60% | 0.52% | 10.54% |
| Retained Earnings | -7.56% | -6.14% | -8.83% | -9.03% | 2.45% |
| Treasury Stock & Other | 12.79% | -224.07% | -0.04% | -12.41% | -54.38% |
| Total Common Equity | -37.40% | -25.37% | -33.15% | -32.10% | 321.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.40% | -25.37% | -33.15% | -32.10% | 321.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.40% | -25.37% | -33.15% | -32.10% | 321.62% |
|
|
|||||